Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Vaccines|June 21, 2020
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored VaccinesCésar López-Camacho, Giuditta De Lorenzo, Jose Luis Slon-Campos, et al.
Ebiomedicine|March 1, 2022
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studiesAlexandra J Spencer, Susan Morris, Marta Ulaszewska, et al.
Nature Communications|June 24, 2018
Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectorsCésar López-Camacho, Peter Abbink, Rafael A Larocca, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Lancet (London, England)|January 25, 2022
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised studySue Ann Costa Clemens, Lily Weckx, Ralf Clemens, et al.
Cell Host & Microbe|December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variantsChang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Craig P Thompson, Nicholas E Grayson, Robert S Paton, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 2, 2024
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in VietnamTran Tan Thanh, Nguyen Thi Kha Tu, Lam Anh Nguyet, et al.
Pageof 8